Growth Metrics

Fulgent Genetics (FLGT) Cash from Operations (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Cash from Operations for 11 consecutive years, with 78143000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations fell 412.35% to 78143000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 101638000.0 through Dec 2025, down 582.61% year-over-year, with the annual reading at 101638000.0 for FY2025, 582.61% down from the prior year.
  • Cash from Operations hit 78143000.0 in Q4 2025 for Fulgent Genetics, down from 11107000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 233179000.0 in Q1 2021 to a low of 78143000.0 in Q4 2025.
  • Historically, Cash from Operations has averaged 36926100.0 across 5 years, with a median of 11116500.0 in 2022.
  • Biggest five-year swings in Cash from Operations: surged 16970.2% in 2021 and later crashed 804.11% in 2025.
  • Year by year, Cash from Operations stood at 77086000.0 in 2021, then crashed by 56.92% to 33207000.0 in 2022, then plummeted by 55.03% to 14933000.0 in 2023, then skyrocketed by 67.53% to 25018000.0 in 2024, then tumbled by 412.35% to 78143000.0 in 2025.
  • Business Quant data shows Cash from Operations for FLGT at 78143000.0 in Q4 2025, 11107000.0 in Q3 2025, and 30171000.0 in Q2 2025.